08-31-2023
JPY/share | |
Price | 2,671.00 |
Dividend | 53.95 |
Earnings | 112.70 |
Cash-flow | 90.54 |
Book value | 1,405.79 |
Equity | 1,391.36 |
Kyowa Hakko Kirin is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Kyowa Hakko Kirin is a company from Japan, and his stocks are publicly traded.
Kyowa Hakko Kirin stock dividend
Kyowa Hakko Kirin paid a total dividend of 29,025 million JPY last year, for a market value of 1,436,998 millions (Market Cap 663,500 millions). Kyowa Hakko Kirin dividend per share is 53.95 JPY, and his stock market price 2,671.00 JPY.
According to the chart below, where dividend yield is displayed, Kyowa Hakko Kirin has a dividend yield of 2.02%, which is lower than the amount offered by the market average , but bigger than Health Care industry. Dividend yields are similar among companies from the same industry, so it is a positive sign for the company.
In addition, you should compare Kyowa Hakko Kirin stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the highest Japan dividend stocks list.
Kyowa Hakko Kirin Dividend Payout
About the ability of Kyowa Hakko Kirin to maintain his current dividend of JPY 53.95 per share, an amount that accounts for 2.02%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Kyowa Hakko Kirin payout on ernings is currently 47.87%, which is higher than the market average, and companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures show that Kyowa Hakko Kirin can have problems to keep with his present dividend yield.
The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Kyowa Hakko Kirin is JPY 90.54 per share, which is higher than the dividend per share paid by the company of JPY 53.95, so the company generates enough cash to maintain his dividend in the future.
The following figure shows payout ratios over earnings and cashflow of Kyowa Hakko Kirin, compared againt world market average, Japan companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.
Kyowa Hakko Kirin Dividend History
Below you will find a table with the historical evolution of Kyowa Hakko Kirin's dividend stock, both in percentage and in JPY, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).
Year | Yield | JPY | Paypout | Shares* |
Present | 2.02% | 53.95 | 47.87% | 538 |
2022 | 1.59% | 48.02 | 42.61% | 537 |
2021 | 1.47% | 46.08 | 45.86% | 537 |
2020 | 1.56% | 43.90 | 31.36% | 537 |
2019 | 1.55% | 39.88 | 33.79% | 537 |
2018 | 1.44% | 29.91 | 32.26% | 547 |
2017 | 1.15% | 25.06 | 73.49% | 547 |
2016 | 1.53% | 24.97 | 45.90% | 547 |
2015 | 1.15% | 24.94 | 47.49% | 547 |
*In millions
Then you can see the evolution of Kyowa Hakko Kirin dividend stock, and compare it with the average of Japan stocks and that of the Pharmaceuticals and Biotechnology stocks.
Kyowa Hakko Kirin Stock performance
Finally, last moth Kyowa Hakko Kirin showed a return of -1.70% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a -14.80% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for Japan and Pharmaceuticals and Biotechnology firms.